Report cover image

Global General Medicines Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 126 Pages
SKU # APRC20353770

Description

Summary

According to APO Research, The global General Medicines market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for General Medicines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for General Medicines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for General Medicines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of General Medicines include Sun Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer and Jiangsu Hengrui Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for General Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Medicines.

The General Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global General Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

General Medicines Segment by Company

Sun Pharmaceutical
Sanofi
Johnson & Johnson
Novartis
Merck
Roche
Eli Lilly
Pfizer
Jiangsu Hengrui Medicine
Bayer
Amgen
AbbVie
AstraZeneca
Zoetis
Vertex Pharmaceuticals
Takeda Pharmaceutical
Seagen
Regeneron Pharmaceuticals
Novo Nordisk
Moderna
Lonza
Horizon Therapeutics
GlaxoSmithKline
Gilead Sciences
Daiichi Sankyō
CVS Health
Chugai Pharmaceutical
Bristol-Myers Squibb
Biogen
Argenx

General Medicines Segment by Type

Over-the-Counter (OTC)
Prescription (Rx)

General Medicines Segment by Application

Antihypertensives
Antibiotics
Antidiabetic Drugs
Antipyretics
Analgesics
Others

General Medicines Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of General Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Medicines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of General Medicines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of General Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

126 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global General Medicines Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global General Medicines Sales Estimates and Forecasts (2020-2031)
1.3 General Medicines Market by Type
1.3.1 Over-the-Counter (OTC)
1.3.2 Prescription (Rx)
1.4 Global General Medicines Market Size by Type
1.4.1 Global General Medicines Market Size Overview by Type (2020-2031)
1.4.2 Global General Medicines Historic Market Size Review by Type (2020-2025)
1.4.3 Global General Medicines Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America General Medicines Sales Breakdown by Type (2020-2025)
1.5.2 Europe General Medicines Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific General Medicines Sales Breakdown by Type (2020-2025)
1.5.4 South America General Medicines Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa General Medicines Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 General Medicines Industry Trends
2.2 General Medicines Industry Drivers
2.3 General Medicines Industry Opportunities and Challenges
2.4 General Medicines Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by General Medicines Revenue (2020-2025)
3.2 Global Top Players by General Medicines Sales (2020-2025)
3.3 Global Top Players by General Medicines Price (2020-2025)
3.4 Global General Medicines Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global General Medicines Major Company Production Sites & Headquarters
3.6 Global General Medicines Company, Product Type & Application
3.7 Global General Medicines Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global General Medicines Market CR5 and HHI
3.8.2 Global Top 5 and 10 General Medicines Players Market Share by Revenue in 2024
3.8.3 2023 General Medicines Tier 1, Tier 2, and Tier 3
4 General Medicines Regional Status and Outlook
4.1 Global General Medicines Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global General Medicines Historic Market Size by Region
4.2.1 Global General Medicines Sales in Volume by Region (2020-2025)
4.2.2 Global General Medicines Sales in Value by Region (2020-2025)
4.2.3 Global General Medicines Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global General Medicines Forecasted Market Size by Region
4.3.1 Global General Medicines Sales in Volume by Region (2026-2031)
4.3.2 Global General Medicines Sales in Value by Region (2026-2031)
4.3.3 Global General Medicines Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 General Medicines by Application
5.1 General Medicines Market by Application
5.1.1 Antihypertensives
5.1.2 Antibiotics
5.1.3 Antidiabetic Drugs
5.1.4 Antipyretics
5.1.5 Analgesics
5.1.6 Others
5.2 Global General Medicines Market Size by Application
5.2.1 Global General Medicines Market Size Overview by Application (2020-2031)
5.2.2 Global General Medicines Historic Market Size Review by Application (2020-2025)
5.2.3 Global General Medicines Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America General Medicines Sales Breakdown by Application (2020-2025)
5.3.2 Europe General Medicines Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific General Medicines Sales Breakdown by Application (2020-2025)
5.3.4 South America General Medicines Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa General Medicines Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Sun Pharmaceutical
6.1.1 Sun Pharmaceutical Comapny Information
6.1.2 Sun Pharmaceutical Business Overview
6.1.3 Sun Pharmaceutical General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sun Pharmaceutical General Medicines Product Portfolio
6.1.5 Sun Pharmaceutical Recent Developments
6.2 Sanofi
6.2.1 Sanofi Comapny Information
6.2.2 Sanofi Business Overview
6.2.3 Sanofi General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi General Medicines Product Portfolio
6.2.5 Sanofi Recent Developments
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Comapny Information
6.3.2 Johnson & Johnson Business Overview
6.3.3 Johnson & Johnson General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson General Medicines Product Portfolio
6.3.5 Johnson & Johnson Recent Developments
6.4 Novartis
6.4.1 Novartis Comapny Information
6.4.2 Novartis Business Overview
6.4.3 Novartis General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis General Medicines Product Portfolio
6.4.5 Novartis Recent Developments
6.5 Merck
6.5.1 Merck Comapny Information
6.5.2 Merck Business Overview
6.5.3 Merck General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck General Medicines Product Portfolio
6.5.5 Merck Recent Developments
6.6 Roche
6.6.1 Roche Comapny Information
6.6.2 Roche Business Overview
6.6.3 Roche General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roche General Medicines Product Portfolio
6.6.5 Roche Recent Developments
6.7 Eli Lilly
6.7.1 Eli Lilly Comapny Information
6.7.2 Eli Lilly Business Overview
6.7.3 Eli Lilly General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eli Lilly General Medicines Product Portfolio
6.7.5 Eli Lilly Recent Developments
6.8 Pfizer
6.8.1 Pfizer Comapny Information
6.8.2 Pfizer Business Overview
6.8.3 Pfizer General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer General Medicines Product Portfolio
6.8.5 Pfizer Recent Developments
6.9 Jiangsu Hengrui Medicine
6.9.1 Jiangsu Hengrui Medicine Comapny Information
6.9.2 Jiangsu Hengrui Medicine Business Overview
6.9.3 Jiangsu Hengrui Medicine General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jiangsu Hengrui Medicine General Medicines Product Portfolio
6.9.5 Jiangsu Hengrui Medicine Recent Developments
6.10 Bayer
6.10.1 Bayer Comapny Information
6.10.2 Bayer Business Overview
6.10.3 Bayer General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer General Medicines Product Portfolio
6.10.5 Bayer Recent Developments
6.11 Amgen
6.11.1 Amgen Comapny Information
6.11.2 Amgen Business Overview
6.11.3 Amgen General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Amgen General Medicines Product Portfolio
6.11.5 Amgen Recent Developments
6.12 AbbVie
6.12.1 AbbVie Comapny Information
6.12.2 AbbVie Business Overview
6.12.3 AbbVie General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 AbbVie General Medicines Product Portfolio
6.12.5 AbbVie Recent Developments
6.13 AstraZeneca
6.13.1 AstraZeneca Comapny Information
6.13.2 AstraZeneca Business Overview
6.13.3 AstraZeneca General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 AstraZeneca General Medicines Product Portfolio
6.13.5 AstraZeneca Recent Developments
6.14 Zoetis
6.14.1 Zoetis Comapny Information
6.14.2 Zoetis Business Overview
6.14.3 Zoetis General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Zoetis General Medicines Product Portfolio
6.14.5 Zoetis Recent Developments
6.15 Vertex Pharmaceuticals
6.15.1 Vertex Pharmaceuticals Comapny Information
6.15.2 Vertex Pharmaceuticals Business Overview
6.15.3 Vertex Pharmaceuticals General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Vertex Pharmaceuticals General Medicines Product Portfolio
6.15.5 Vertex Pharmaceuticals Recent Developments
6.16 Takeda Pharmaceutical
6.16.1 Takeda Pharmaceutical Comapny Information
6.16.2 Takeda Pharmaceutical Business Overview
6.16.3 Takeda Pharmaceutical General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Takeda Pharmaceutical General Medicines Product Portfolio
6.16.5 Takeda Pharmaceutical Recent Developments
6.17 Seagen
6.17.1 Seagen Comapny Information
6.17.2 Seagen Business Overview
6.17.3 Seagen General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Seagen General Medicines Product Portfolio
6.17.5 Seagen Recent Developments
6.18 Regeneron Pharmaceuticals
6.18.1 Regeneron Pharmaceuticals Comapny Information
6.18.2 Regeneron Pharmaceuticals Business Overview
6.18.3 Regeneron Pharmaceuticals General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Regeneron Pharmaceuticals General Medicines Product Portfolio
6.18.5 Regeneron Pharmaceuticals Recent Developments
6.19 Novo Nordisk
6.19.1 Novo Nordisk Comapny Information
6.19.2 Novo Nordisk Business Overview
6.19.3 Novo Nordisk General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Novo Nordisk General Medicines Product Portfolio
6.19.5 Novo Nordisk Recent Developments
6.20 Moderna
6.20.1 Moderna Comapny Information
6.20.2 Moderna Business Overview
6.20.3 Moderna General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Moderna General Medicines Product Portfolio
6.20.5 Moderna Recent Developments
6.21 Lonza
6.21.1 Lonza Comapny Information
6.21.2 Lonza Business Overview
6.21.3 Lonza General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Lonza General Medicines Product Portfolio
6.21.5 Lonza Recent Developments
6.22 Horizon Therapeutics
6.22.1 Horizon Therapeutics Comapny Information
6.22.2 Horizon Therapeutics Business Overview
6.22.3 Horizon Therapeutics General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Horizon Therapeutics General Medicines Product Portfolio
6.22.5 Horizon Therapeutics Recent Developments
6.23 GlaxoSmithKline
6.23.1 GlaxoSmithKline Comapny Information
6.23.2 GlaxoSmithKline Business Overview
6.23.3 GlaxoSmithKline General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.23.4 GlaxoSmithKline General Medicines Product Portfolio
6.23.5 GlaxoSmithKline Recent Developments
6.24 Gilead Sciences
6.24.1 Gilead Sciences Comapny Information
6.24.2 Gilead Sciences Business Overview
6.24.3 Gilead Sciences General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Gilead Sciences General Medicines Product Portfolio
6.24.5 Gilead Sciences Recent Developments
6.25 Daiichi Sankyō
6.25.1 Daiichi Sankyō Comapny Information
6.25.2 Daiichi Sankyō Business Overview
6.25.3 Daiichi Sankyō General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Daiichi Sankyō General Medicines Product Portfolio
6.25.5 Daiichi Sankyō Recent Developments
6.26 CVS Health
6.26.1 CVS Health Comapny Information
6.26.2 CVS Health Business Overview
6.26.3 CVS Health General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.26.4 CVS Health General Medicines Product Portfolio
6.26.5 CVS Health Recent Developments
6.27 Chugai Pharmaceutical
6.27.1 Chugai Pharmaceutical Comapny Information
6.27.2 Chugai Pharmaceutical Business Overview
6.27.3 Chugai Pharmaceutical General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Chugai Pharmaceutical General Medicines Product Portfolio
6.27.5 Chugai Pharmaceutical Recent Developments
6.28 Bristol-Myers Squibb
6.28.1 Bristol-Myers Squibb Comapny Information
6.28.2 Bristol-Myers Squibb Business Overview
6.28.3 Bristol-Myers Squibb General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.28.4 Bristol-Myers Squibb General Medicines Product Portfolio
6.28.5 Bristol-Myers Squibb Recent Developments
6.29 Biogen
6.29.1 Biogen Comapny Information
6.29.2 Biogen Business Overview
6.29.3 Biogen General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.29.4 Biogen General Medicines Product Portfolio
6.29.5 Biogen Recent Developments
6.30 Argenx
6.30.1 Argenx Comapny Information
6.30.2 Argenx Business Overview
6.30.3 Argenx General Medicines Sales, Revenue and Gross Margin (2020-2025)
6.30.4 Argenx General Medicines Product Portfolio
6.30.5 Argenx Recent Developments
7 North America by Country
7.1 North America General Medicines Sales by Country
7.1.1 North America General Medicines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America General Medicines Sales by Country (2020-2025)
7.1.3 North America General Medicines Sales Forecast by Country (2026-2031)
7.2 North America General Medicines Market Size by Country
7.2.1 North America General Medicines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America General Medicines Market Size by Country (2020-2025)
7.2.3 North America General Medicines Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe General Medicines Sales by Country
8.1.1 Europe General Medicines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe General Medicines Sales by Country (2020-2025)
8.1.3 Europe General Medicines Sales Forecast by Country (2026-2031)
8.2 Europe General Medicines Market Size by Country
8.2.1 Europe General Medicines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe General Medicines Market Size by Country (2020-2025)
8.2.3 Europe General Medicines Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific General Medicines Sales by Country
9.1.1 Asia-Pacific General Medicines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific General Medicines Sales by Country (2020-2025)
9.1.3 Asia-Pacific General Medicines Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific General Medicines Market Size by Country
9.2.1 Asia-Pacific General Medicines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific General Medicines Market Size by Country (2020-2025)
9.2.3 Asia-Pacific General Medicines Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America General Medicines Sales by Country
10.1.1 South America General Medicines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America General Medicines Sales by Country (2020-2025)
10.1.3 South America General Medicines Sales Forecast by Country (2026-2031)
10.2 South America General Medicines Market Size by Country
10.2.1 South America General Medicines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America General Medicines Market Size by Country (2020-2025)
10.2.3 South America General Medicines Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa General Medicines Sales by Country
11.1.1 Middle East and Africa General Medicines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa General Medicines Sales by Country (2020-2025)
11.1.3 Middle East and Africa General Medicines Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa General Medicines Market Size by Country
11.2.1 Middle East and Africa General Medicines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa General Medicines Market Size by Country (2020-2025)
11.2.3 Middle East and Africa General Medicines Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 General Medicines Value Chain Analysis
12.1.1 General Medicines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 General Medicines Production Mode & Process
12.2 General Medicines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 General Medicines Distributors
12.2.3 General Medicines Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.